A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
Clinical trial NCT01711723 · COMPLETED
Trial details
- NCT number
- NCT01711723
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-29
- Primary completion
- 2013-03-25
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.